CIVIC LANE Medicine is entering a period in which gene therapies, personalised treatments, AI-designed drugs and regenerative medicine could transform diseases that were once extremely difficult to treat. However, developing these technologies requires enormous investment, and healthcare systems cannot fund every innovation equally. Some people would prioritise cures for deadly diseases, while others might focus on preventing age-related illness or making existing medicines cheaper and more accessible. The question is not simply what science can achieve, but which breakthroughs society should prioritise first.